Search Results 361-370 of 18182 for monoclonal antibody
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...
Prior use of monoclonal antibody within 4 weeks before Cycle 1, Day 1 · Treatment with radiotherapy, thalidomide, lenalidomide, bortezomib, any chemotherapeutic ...
Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. It is not known whether giving olaparib and ...
Research · Research · Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured · Science Saturday: Opioids ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
August 30, 2021. Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal ...
Research · Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured · Science Saturday: Opioids provide low ...
Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...
Mayo Clinic Staff. December 5, 2020. Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.